FR2235367B1 - - Google Patents

Info

Publication number
FR2235367B1
FR2235367B1 FR7422530A FR7422530A FR2235367B1 FR 2235367 B1 FR2235367 B1 FR 2235367B1 FR 7422530 A FR7422530 A FR 7422530A FR 7422530 A FR7422530 A FR 7422530A FR 2235367 B1 FR2235367 B1 FR 2235367B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR7422530A
Other versions
FR2235367A1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pfizer Health AB
Original Assignee
Pharmacia AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from SE7309096A external-priority patent/SE379861B/xx
Priority claimed from SE7402350A external-priority patent/SE7402350L/
Application filed by Pharmacia AB filed Critical Pharmacia AB
Publication of FR2235367A1 publication Critical patent/FR2235367A1/fr
Application granted granted Critical
Publication of FR2235367B1 publication Critical patent/FR2235367B1/fr
Expired legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/563—Immunoassay; Biospecific binding assay; Materials therefor involving antibody fragments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/80—Fluorescent dyes, e.g. rhodamine
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/828—Protein A
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/806—Antigenic peptides or proteins
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
    • Y10S530/862—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof involving IgE or IgD

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Urology & Nephrology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR7422530A 1973-06-28 1974-06-27 Expired FR2235367B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE7309096A SE379861B (fr) 1973-06-28 1973-06-28
SE7402350A SE7402350L (sv) 1974-02-22 1974-02-22 Forfarande for merkning av immunglobulin eller dess fc-fragment jemte hjelpmedel for anvendning vid forfarandet.

Publications (2)

Publication Number Publication Date
FR2235367A1 FR2235367A1 (fr) 1975-01-24
FR2235367B1 true FR2235367B1 (fr) 1976-10-22

Family

ID=26656382

Family Applications (2)

Application Number Title Priority Date Filing Date
FR7422530A Expired FR2235367B1 (fr) 1973-06-28 1974-06-27
FR7422531A Expired FR2235368B1 (fr) 1973-06-28 1974-06-27

Family Applications After (1)

Application Number Title Priority Date Filing Date
FR7422531A Expired FR2235368B1 (fr) 1973-06-28 1974-06-27

Country Status (6)

Country Link
US (1) US3966898A (fr)
JP (1) JPS5840143B2 (fr)
DE (2) DE2430356A1 (fr)
FR (2) FR2235367B1 (fr)
GB (2) GB1448613A (fr)
NL (1) NL7408787A (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2322562C2 (de) * 1972-11-06 1984-03-29 Pharmacia AB, Uppsala Verfahren zur Bestimmung von Antigenen in einer Probe
US4169138A (en) * 1974-05-29 1979-09-25 Pharmacia Diagnostics Ab Method for the detection of antibodies
IL47372A (en) * 1975-05-27 1979-10-31 Yeda Res & Dev Fab'dimers bound to daunomycin or adriamycin,their preparation and pharmaceutical compositions containing same
US4189466A (en) * 1975-09-19 1980-02-19 Technical Research Affiliates, Inc. Detection of rheumatoid factor by antibody sensitized microbial particles
DE2644622C3 (de) * 1976-10-02 1979-11-29 Behringwerke Ag, 3550 Marburg Extraktion von Mikroorganismen und diese enthaltende diagnostische Mittel
ES471585A1 (es) * 1977-07-15 1979-01-16 Behringwerke Ag Procedimiento para la determinacion de reactivos fc
US4258130A (en) * 1977-12-12 1981-03-24 Hunt-Wesson Foods, Inc. Method for detection of antigens
US4292403A (en) * 1978-08-24 1981-09-29 Akzona Incorporated Detection and/or determination of IgM, IgA, IgD and IgE immunoglobulins
US4430318A (en) 1978-11-29 1984-02-07 The United States Of America As Represented By The Department Of Health And Human Services Immunoassay utilizing 125 I Protein A
US4236893A (en) * 1979-04-09 1980-12-02 Minnesota Mining And Manufacturing Company Method for the assay of classes of antigen-specific antibodies
DE2923139A1 (de) * 1979-06-07 1980-12-18 Boehringer Mannheim Gmbh Verfahren zur herstellung von immunologisch aktiven enzymmarkierten konjugaten
US4281061A (en) * 1979-07-27 1981-07-28 Syva Company Double antibody for enhanced sensitivity in immunoassay
DE2952478A1 (de) * 1979-12-27 1981-07-30 Merck Patent Gmbh, 6100 Darmstadt Verfahren und mittel zur immunologischen bestimmung von enzymen
ATE10399T1 (de) * 1980-09-08 1984-12-15 International Diagnostic Technology, Inc. Fluoreszierendes reagenz und immunofluoreszenzbestimmungsmethode.
NL8102178A (nl) * 1981-05-02 1982-12-01 Stichting Centraal Lab Werkwijze voor het aantonen van tegen bepaalde antigenen gerichte antistoffen, alsmede inrichting en reagentia voor het uitvoeren van deze werkwijze.
FR2530818B1 (fr) * 1981-11-30 1985-12-27 Inst Technologie Surfaces Ac Procede de preparation d'un oligopeptide terminal specifique de l'antigene de surface d'un germe infectieux, determination de ce germe et dispositif pour son identification
US4469787A (en) * 1982-05-14 1984-09-04 Mallinckrodt Inc. Immunoassay involving soluble complex of second antibody and labeled binding protein
DE3231204A1 (de) * 1982-08-21 1984-03-01 Boehringer Ingelheim Diagnostika GmbH, 8046 Garching Antikoerper gegen bakterielle peptidoglycane, verfahren zu ihrer herstellung und methoden zu ihrer quantitativen bestimmung
DE3314812A1 (de) * 1983-04-23 1984-10-25 Battelle-Institut E.V., 6000 Frankfurt Mittel zum antigen/antikoerper-nachweis
FR2549230B1 (fr) * 1983-06-14 1986-04-11 Bio Merieux Procede de detection d'un oligomere dans un milieu liquide contenant des monomeres correspondants, dispositif pour la mise en oeuvre de ce procede et application notamment a la recherche d'allergenes
DE3328832A1 (de) * 1983-08-10 1985-02-28 Boehringer Ingelheim Diagnostika GmbH, 8046 Garching Reagenz und verfahren zur quantitativen bestimmung von antikoerpern
DE3331627A1 (de) * 1983-09-01 1985-03-21 Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V., 3400 Göttingen Verfahren zur immunologischen bestimmung fuer proteine in koerperfluessigkeiten, unter verwendung monovalenter antikoerperfragmente
FR2562252B1 (fr) * 1984-03-27 1988-01-22 Inst Nat Sante Rech Med Procede de dosage immunoenzymatique sans etape de separation et reactifs et necessaires pour sa mise en oeuvre
US4900660A (en) * 1985-11-25 1990-02-13 University Of Florida Streptococcal fc rc
US4883754A (en) * 1986-03-06 1989-11-28 University Of Florida Research Foundation Bacterial FC receptors
DE3744826C2 (de) * 1986-04-04 1995-05-18 Hoffmann La Roche Verfahren zum Nachweis von Antikörpern gegen AIDS-Viren in menschlichen Seren und entsprechenden Test Kits
IT1198233B (it) * 1986-12-23 1988-12-21 Eniricerche Spa Metodo per la determinazione di anticorpi antisporozoita di p. falciparum nel sangue umano
JPH0640945A (ja) * 1992-07-23 1994-02-15 Kureha Chem Ind Co Ltd Ｆｃフラグメント結合抗腫瘍剤
US5541059A (en) * 1993-12-29 1996-07-30 Chu; Albert E. Immunoassay device having an internal control of protein A and methods of using same
US20050233390A1 (en) * 2003-04-09 2005-10-20 Allen John W Device including a proteinaceous factor, a recombinant proteinaceous factor, and a nucleotide sequence encoding the proteinaceous factor
US20050048468A1 (en) * 2003-08-27 2005-03-03 Bio-Rad Laboratories, Inc. Multiconstituent liquid lgG and IgM calibrators
KR101864622B1 (ko) 2016-12-22 2018-06-07 엘지전자 주식회사 스위칭 모듈 구동 회로

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5027476B2 (fr) * 1972-11-17 1975-09-08
US3859430A (en) * 1973-01-29 1975-01-07 Us Navy Radioactive iodine labeling of viruses, enzymes and flourescene isothyiocyanate

Also Published As

Publication number Publication date
DE2430357C2 (de) 1983-08-11
DE2430356A1 (de) 1975-01-16
FR2235368A1 (fr) 1975-01-24
GB1448613A (en) 1976-09-08
FR2235367A1 (fr) 1975-01-24
JPS5840143B2 (ja) 1983-09-03
US3966898A (en) 1976-06-29
FR2235368B1 (fr) 1976-10-22
GB1448344A (en) 1976-09-02
DE2430357A1 (de) 1975-01-16
NL7408787A (fr) 1974-12-31
JPS5063124A (fr) 1975-05-29
DE2430356C2 (fr) 1987-09-10

Similar Documents

Publication Publication Date Title
AR201758A1 (fr)
AU465372B2 (fr)
AR201235Q (fr)
AR201231Q (fr)
FR2235367B1 (fr)
AU474593B2 (fr)
AU474511B2 (fr)
AU474838B2 (fr)
AU465453B2 (fr)
AU465434B2 (fr)
AU471343B2 (fr)
AU450229B2 (fr)
AU476714B2 (fr)
AR201229Q (fr)
AU476696B2 (fr)
AU466283B2 (fr)
AR199451A1 (fr)
AU477823B2 (fr)
AU476873B1 (fr)
AR210729A1 (fr)
AU447540B2 (fr)
AR200256A1 (fr)
AR195948A1 (fr)
AR197627A1 (fr)
AR196382A1 (fr)

Legal Events

Date Code Title Description
ST Notification of lapse